Eroom's Law

ScientificConcept

The observation that drug discovery is becoming slower and more expensive over time, despite improvements in technology.


First Mentioned

8/25/2026, 5:23:29 AM

Last Updated

8/25/2026, 5:26:25 AM

Research Retrieved

8/25/2026, 5:26:25 AM

Summary

Eroom's Law describes the counterintuitive trend in drug discovery where, despite technological advancements, the process is becoming progressively slower and more expensive. This phenomenon, first observed in the 1980s, states that the inflation-adjusted cost of developing a new drug approximately doubles every nine years. The name "Eroom's Law" is a deliberate inversion of Moore's Law, highlighting the contrast with the exponential progress seen in other technological fields. This concept was introduced by Jack Scannell and his colleagues in 2012 in the journal *Nature Reviews Drug Discovery*. The stagnation in drug discovery, referred to as Eroom's Law, has been a point of discussion in broader conversations about scientific funding and reform, with critics pointing to it as an example of inefficiencies in government-funded research.

Research Data
Extracted Attributes
    Eroom's law

    Eroom's law is the observation that drug discovery is becoming slower and more expensive over time, despite improvements in technology (such as high-throughput screening, biotechnology, combinatorial chemistry, and computational drug design), a trend first observed in the 1980s. The inflation-adjusted cost of developing a new drug roughly doubles every nine years. In order to highlight the contrast with the exponential advancements of other forms of technology (such as transistors) over time, the name given to the observation is Moore's law spelled backwards. The term was coined by Jack Scannell and colleagues in 2012 in Nature Reviews Drug Discovery.

    Web Search Results